Professor | De-Cai Yu | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	De-Cai Yu
Contact Information	yudecai@nju.edu.cn
Language ability	Chinese, English
Province	Jiangsu

Upload Avatar (500 x 500)

Name

De-Cai Yu

Contact Information

yudecai@nju.edu.cn

Language ability

Chinese, English

Province

Jiangsu

University/Lab Affiliation and Title	Nanjing University
Faculty	Medical School
Academic Background & Achievements	2007.9-2008.3: Research at Liver Disease Research Center, Department of Surgery, University of Hong Kong 2011.7-2012.8: Research at MUSC Transplant Center, USA 2017.8-2017.9: Research at ASAN Medical Center, South Korea Supervised over 70 high-level academic papers, including over 30 SCI papers as first or corresponding author
Work Experience	2002.8-2006.8 - Nanjing Drum Tower Hospital - Resident Physician 2006.9-2012.9 - Nanjing Drum Tower Hospital - Attending Physician 2012.10-2018.12 - Nanjing Drum Tower Hospital - Associate Chief Physician 2012.6-present - Nanjing University - Master's Supervisor 2017.6-present - Nanjing University - Doctoral Supervisor 2019.1-present - Nanjing Drum Tower Hospital - Chief Physician 2019.7-present - Nanjing University - Professor
Awards	2015: Jiangsu Medical Award Second Prize for research on angiogenesis microenvironment and targeted therapy of hepatocellular carcinoma (Second Contributor) 2015: Chinese Medical Science and Technology Award Third Prize for research on angiogenesis microenvironment and targeted therapy of hepatocellular carcinoma (Second Contributor)

University/Lab Affiliation and Title

Nanjing University

Faculty

Medical School

Academic Background & Achievements

2007.9-2008.3: Research at Liver Disease Research Center, Department of Surgery, University of Hong Kong
2011.7-2012.8: Research at MUSC Transplant Center, USA
2017.8-2017.9: Research at ASAN Medical Center, South Korea
Supervised over 70 high-level academic papers, including over 30 SCI papers as first or corresponding author

Work Experience

2002.8-2006.8 - Nanjing Drum Tower Hospital - Resident Physician
2006.9-2012.9 - Nanjing Drum Tower Hospital - Attending Physician
2012.10-2018.12 - Nanjing Drum Tower Hospital - Associate Chief Physician
2012.6-present - Nanjing University - Master's Supervisor
2017.6-present - Nanjing University - Doctoral Supervisor
2019.1-present - Nanjing Drum Tower Hospital - Chief Physician
2019.7-present - Nanjing University - Professor

Awards

2015: Jiangsu Medical Award Second Prize for research on angiogenesis microenvironment and targeted therapy of hepatocellular carcinoma (Second Contributor)
2015: Chinese Medical Science and Technology Award Third Prize for research on angiogenesis microenvironment and targeted therapy of hepatocellular carcinoma (Second Contributor)

Areas of Focus	Liver Cancer Metabolism Liver Cancer Biotherapy Research Minimally Invasive Techniques in Liver Surgery
Publications	Laennec's approach for laparoscopic anatomic hepatectomy based on Laennec's capsule, Hu Y, Shi J, Wang S, Zhang W, Sun X, Sun B, Yu D, 2019 Loss of Xanthine Oxidoreductase Potentiates Propagation of Hepatocellular Carcinoma Stem Cells, Sun Q, Zhang Z, Lu Y, Liu Q, Xu X, Xu J, Liu Y, Yu H, Yu D, Sun B, 2019 Fludarabine as an Adjuvant Improves Newcastle Disease Virus-Mediated Antitumor Immunity in Hepatocellular Carcinoma, Meng G, Fei Z, Fang M, Li B, Chen A, Xu C, Xia M, Yu D, Wei J, 2019 Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway, Li B, Cao Y, Meng G, Qian L, Xu T, Yan C, Luo O, Wang S, Wei J, Ding Y, Yu D, 2019 Glissonian approach combined with major hepatic vein first for laparoscopic anatomic hepatectomy, Yu DC, Wu XY, Sun XT, Ding YT, 2018 Liver-enriched Genes are Associated with the Prognosis of Patients with Hepatocellular Carcinoma, Li B, Xu T, Liu C, Meng G, Sun Y, Qian L, Wang S, Wei J, Yu D, Ding Y, 2018 Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma, Li B, Feng W, Luo O, Xu T, Cao Y, Wu H, Yu D, Ding Y, 2017 Integrative analysis of copy number and transcriptional expression profiles in esophageal cancer to identify a novel driver gene for therapy, Dong G, Mao Q, Yu D, Zhang Y, Qiu M, Dong G, Chen Q, Xia W, Wang J, Xu L, Jiang F, 2017 Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model, Su L, Zhang H, Yan C, Chen A, Meng G, Wei J, Yu D, Ding Y, 2016 Radiological score for hemorrhage in the patients with portal hypertension, Wei Ge, Yi Wang, Ya-Juan Cao, Min Xie, Yi-Tao Ding, Ming Zhang, De-Cai Yu, 2015 Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma, Yu D, Shi X, Meng G, Chen J, Yan C, Jiang Y, Wei J, Ding Y, 2015 Lymphocele: a clinical analysis of 19 cases, Ge W, Yu DC, Chen J, Shi XB, Su L, Ye Q, Ding YT, 2015

Areas of Focus

Liver Cancer Metabolism
Liver Cancer Biotherapy Research
Minimally Invasive Techniques in Liver Surgery

Publications

Laennec's approach for laparoscopic anatomic hepatectomy based on Laennec's capsule, Hu Y, Shi J, Wang S, Zhang W, Sun X, Sun B, Yu D, 2019
Loss of Xanthine Oxidoreductase Potentiates Propagation of Hepatocellular Carcinoma Stem Cells, Sun Q, Zhang Z, Lu Y, Liu Q, Xu X, Xu J, Liu Y, Yu H, Yu D, Sun B, 2019
Fludarabine as an Adjuvant Improves Newcastle Disease Virus-Mediated Antitumor Immunity in Hepatocellular Carcinoma, Meng G, Fei Z, Fang M, Li B, Chen A, Xu C, Xia M, Yu D, Wei J, 2019
Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway, Li B, Cao Y, Meng G, Qian L, Xu T, Yan C, Luo O, Wang S, Wei J, Ding Y, Yu D, 2019
Glissonian approach combined with major hepatic vein first for laparoscopic anatomic hepatectomy, Yu DC, Wu XY, Sun XT, Ding YT, 2018
Liver-enriched Genes are Associated with the Prognosis of Patients with Hepatocellular Carcinoma, Li B, Xu T, Liu C, Meng G, Sun Y, Qian L, Wang S, Wei J, Yu D, Ding Y, 2018
Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma, Li B, Feng W, Luo O, Xu T, Cao Y, Wu H, Yu D, Ding Y, 2017
Integrative analysis of copy number and transcriptional expression profiles in esophageal cancer to identify a novel driver gene for therapy, Dong G, Mao Q, Yu D, Zhang Y, Qiu M, Dong G, Chen Q, Xia W, Wang J, Xu L, Jiang F, 2017
Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model, Su L, Zhang H, Yan C, Chen A, Meng G, Wei J, Yu D, Ding Y, 2016
Radiological score for hemorrhage in the patients with portal hypertension, Wei Ge, Yi Wang, Ya-Juan Cao, Min Xie, Yi-Tao Ding, Ming Zhang, De-Cai Yu, 2015
Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma, Yu D, Shi X, Meng G, Chen J, Yan C, Jiang Y, Wei J, Ding Y, 2015
Lymphocele: a clinical analysis of 19 cases, Ge W, Yu DC, Chen J, Shi XB, Su L, Ye Q, Ding YT, 2015

Liver Cancer Metabolism Biotherapy Minimally Invasive Laparoscopic Surgery Hepatectomy Liver Transplant Oncolytic Virus Biomarkers Clinical Translation

Xueping Qiu - Wuhan University

Meiyu Geng - University of Chinese Academy of Sciences

Min Huang - University of Chinese Academy of Sciences

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us